Literature DB >> 7522227

Low mature TGF-beta 2 levels in aqueous humor during uveitis.

J H de Boer1, J Limpens, S Orengo-Nania, P T de Jong, E La Heij, A Kijlstra.   

Abstract

PURPOSE: To investigate whether transforming growth factor-beta 2 (TGF-beta 2), a strong immunosuppressive factor normally present in aqueous humor, is involved in the inflammatory process of clinical uveitis.
METHODS: Mature TGF-beta 2 levels were determined in aqueous humor samples of 9 patients with Fuchs' heterochromic cyclitis, aqueous humor samples of 21 patients with other uveitis entities, and vitreous fluid samples of 19 patients with uveitis by using a commercially available sandwich ELISA: Total TGF-beta 2 levels in ocular fluids were measured after heat activation. Aqueous humor samples from patients with cataract and glaucoma and vitreous fluid samples from eye bank eyes were tested as controls. Albumin levels, determined by radial immunodiffusion, were used as a measure of the disruption of the blood aqueous barrier.
RESULTS: Significantly lower mature TGF-beta 2 levels were detected in aqueous humor samples of patients with uveitis, compared to the two control groups without intraocular inflammation. Samples of patients with uveitis without detectable mature TGF-beta 2 did contain latent TGF-beta 2 levels (504 to 6024 pg/ml). In aqueous humor, there was a significant negative correlation between mature TGF-beta 2 and albumin levels. No mature TGF-beta could be detected in vitreous fluid. Total TGF-beta 2 levels in vitreous fluid were significantly lower in samples from patients with uveitis than in samples from eye bank eyes.
CONCLUSION: These results indicate that the mature TGF-beta 2 levels in aqueous humor and the total TGF-beta 2 levels in vitreous fluid are reduced during ocular inflammation. In aqueous humor, this might be caused by binding of mature TGF-beta to serum proteins, for instance, alpha 2-macroglobulin, or by a disturbance in the activation process of latent TGF-beta 2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522227

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  20 in total

1.  Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.

Authors:  M Boulton; Z Gregor; D McLeod; D Charteris; J Jarvis-Evans; P Moriarty; A Khaliq; D Foreman; D Allamby; B Bardsley
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

2.  Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.

Authors:  Andrew W Taylor; Henry J Kaplan
Journal:  Ocul Immunol Inflamm       Date:  2010-12       Impact factor: 3.070

3.  Surgical denervation of ocular sympathetic afferents decreases local transforming growth factor-beta and abolishes immune privilege.

Authors:  Jose L Vega; Hiroshi Keino; Sharmila Masli
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

Review 4.  Fibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract.

Authors:  F J Lovicu; E H Shin; J W McAvoy
Journal:  Exp Eye Res       Date:  2015-05-21       Impact factor: 3.467

5.  Estrogen protects lenses against cataract induced by transforming growth factor-beta (TGFbeta).

Authors:  A M Hales; C G Chamberlain; C R Murphy; J W McAvoy
Journal:  J Exp Med       Date:  1997-01-20       Impact factor: 14.307

Review 6.  Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype?

Authors:  Kenneth G-J Ooi; Grazyna Galatowicz; Virginia L Calder; Susan L Lightman
Journal:  Clin Med Res       Date:  2006-12

7.  Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta2) by human retinal pigment epithelial cells.

Authors:  G M Holtkamp; A F De Vos; R Peek; A Kijlsta
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

8.  Vitreous body affects activation and maturation of monocytes into macrophages.

Authors:  R Osuský; S M Walker; S J Ryan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-10       Impact factor: 3.117

9.  Transforming growth factor-beta expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis.

Authors:  C N Nagineni; B Detrick; J J Hooks
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

10.  Transforming growth factor-beta levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes.

Authors:  Seong Hee Min; Tong-Il Lee; Yun Seok Chung; Hwang Ki Kim
Journal:  Korean J Ophthalmol       Date:  2006-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.